Schizophrenia is a mental disorder that makes it hard to tell the difference between what is real and not real.
It also makes it hard to think clearly, have normal emotional responses, and act normally in social situations.
Psychosis - schizophrenia; Psychotic disorders - schizophrenia
Schizophrenia is a complex illness. Mental health experts are not sure what causes it. Genes may play a role.
Schizophrenia occurs in just as many men as women. It usually begins in the teen or young adult years, but it may begin later in life. In women, it tends to begin slightly later.
Schizophrenia in children usually begins after age 5. Childhood schizophrenia is rare and can be hard to tell apart from other developmental problems.
Symptoms usually develop slowly over months or years. The person may have many symptoms, or only a few.
Early symptoms may include:
As the illness continues, the person may have problems with thinking, emotions, and behavior, including:
There are no medical tests to diagnose schizophrenia. A psychiatrist should examine the person and make the diagnosis. The diagnosis is made based on an interview of the person and family members.
The psychiatrist will ask about the following:
Brain scans (such as CT or MRI) and blood tests may help rule out other conditions that have similar symptoms.
During an episode of schizophrenia, the person may need to stay in the hospital for safety reasons.
Antipsychotic drugs are the most effective treatment for schizophrenia. They change the balance of chemicals in the brain and can help control symptoms.
These drugs can cause side effects, but many side effects can be managed. Side effects should not prevent the person from getting treated for this serious condition.
Common side effects from antipsychotics may include:
Long-term use of antipsychotics may increase the risk for a movement disorder called tardive dyskinesia. This condition causes repeated movements that the person cannot control. Call the health care provider right away if you think you or your family member may have this condition due to the medicine.
When schizophrenia does not improve with antipsychotics, other medicines may be tried.
Schizophrenia is a life-long illness. Most people with this condition need to stay on antipsychotics for life.
SUPPORT PROGRAMS AND THERAPIES
Support therapy may be helpful for many people with schizophrenia. Behavioral techniques, such as social skills training, can help the person function better in social and work situations. Job training and relationship-building classes are also important.
Family members and caregivers are very important during treatment. Therapy can teach important skills, such as:
Outlook is hard to predict. Most of the time, symptoms improve with medicines. But many people may have trouble functioning. They are at risk for repeated episodes, especially during the early stages of the illness. People with schizophrenia are also at increased risk for suicide.
People with schizophrenia may need housing, job training, and other community support programs. Those with the most severe forms of this disorder may not be able to live alone. They may need to live in group homes or other long-term, structured residences.
Symptoms are very likely to return when medicine is stopped.
Having schizophrenia increases the risk for:
Call your provider if you (or a family member):
Schizophrenia cannot be prevented.
Symptoms may be prevented by taking medicine exactly as the doctor instructed. Symptoms are likely to return if medicine is stopped.
Changing or stopping medicines should only be done by the doctor who prescribed them.
American Psychiatric Association. Schizophrenia spectrum and other psychotic disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:87-122.
Freudenreich O, Brown HE, Holt DJ. Psychosis and schizophrenia. In: Stern TA, Fava M, Wilens TE, Rosenbaum JF, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 2nd ed. Philadelphia, PA: Elsevier; 2016:chap 28.
Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399(10323):473-486. PMID: 35093231 pubmed.ncbi.nlm.nih.gov/35093231/.
Lee ES, Kronsberg H, Findling RL. Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children. Child Adolesc Psychiatr Clin N Am. 2020;29(1):183-210. PMID: 31708047 pubmed.ncbi.nlm.nih.gov/31708047/.
McClellan J, Stock S; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013;52(9):976-990. PMID: 23972700 pubmed.ncbi.nlm.nih.gov/23972700/.
Reviewed By: Fred K. Berger, MD, addiction and forensic psychiatrist, Scripps Memorial Hospital, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.